Donna F. Zarcone - 24 Apr 2024 Form 4 Insider Report for Cigna Group (CI)

Role
Director
Signature
Matthew Arnold, attorney-in-fact
Issuer symbol
CI
Transactions as of
24 Apr 2024
Transactions value $
$0
Form type
4
Filing time
26 Apr 2024, 17:14:26
Previous filing
14 Mar 2024
Next filing
13 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Award $0 +539 +2.11% $0.00 26.1K 24 Apr 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person's economic interest in The Cigna Group securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of The Cigna Group stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than The Cigna Group stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for The Cigna Group and pages 53 and 128 of The Cigna Group's proxy statement filed with the SEC on March 15, 2024.

Remarks:

Exhibit List: EX-24 Power of Attorney poazarcone.txt